Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054795
Filing Date
2021-11-05
Accepted
2021-11-05 11:30:53
Documents
80
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-10q_20210930.htm   iXBRL 10-Q 2635556
2 EX-31.1 eypt-ex311_6.htm EX-31.1 18961
3 EX-31.2 eypt-ex312_9.htm EX-31.2 19184
4 EX-32.1 eypt-ex321_7.htm EX-32.1 6179
5 EX-32.2 eypt-ex322_8.htm EX-32.2 6264
  Complete submission text file 0001564590-21-054795.txt   9807855

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eypt-20210930.xsd EX-101.SCH 75126
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eypt-20210930_cal.xml EX-101.CAL 52114
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eypt-20210930_def.xml EX-101.DEF 255543
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20210930_lab.xml EX-101.LAB 521965
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20210930_pre.xml EX-101.PRE 410019
11 EXTRACTED XBRL INSTANCE DOCUMENT eypt-10q_20210930_htm.xml XML 1873639
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 211383176
SIC: 3826 Laboratory Analytical Instruments